Gene silencing of c-Met leads to brain metastasis inhibitory effects
- 27 April 2013
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 30 (7) , 845-854
Abstract
An unfortunate consequence of improvements in the treatments of advanced primary cancers is the concurrent increase of metastatic brain tumors. Despite of unfavorable clinical prognosis, radiation therapy is still the only viable treatment option for brain metastases. Expression of c-Met induces cell migration and invasion in many cancers, which are indispensable steps for metastasis. Accordingly, we examined the effects of gene silencing of c-Met on brain metastasis to evaluate the possibility of c-Met as a potential target. MDA-MB-435 cells were transfected with c-Met targeting short hairpin RNAs (shRNAs). Effects of c-Met shRNAs on the expression of epithelial mesenchymal transition (EMT) related proteins, in vitro migration, and in vivo brain metastasis were examined. Expression of mesenchymal markers and in vitro migration of MDA-MB-435 cells were significantly inhibited by introduction of c-Met shRNAs. When c-Met-silenced MDA-MB-435 cells were stereotactically implanted into the brains of immune-compromised mice or injected into the right internal carotid arteries, c-Met-silenced MDA-MB-435 cells produced significantly smaller tumor masses or survival time was significantly prolonged, respectively, compared with MDA-MB-435 cells transfected with control shRNA. The data reveal the novel function of c-Met in the process of brain metastasis and its potential as a preventive and/or therapeutic target in this disease.Keywords
This publication has 24 references indexed in Scilit:
- Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer CellsCancer Research, 2010
- Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain MetastasisThe American Journal of Pathology, 2010
- The Met receptor tyrosine kinase and basal breast cancerCell Cycle, 2010
- Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in CancerClinical Cancer Research, 2009
- Triple-Negative Breast Cancer: Risk Factors to Potential TargetsClinical Cancer Research, 2008
- Protein Profiling of Human Breast Tumor Cells Identifies Novel Biomarkers Associated with Molecular SubtypesMolecular & Cellular Proteomics, 2008
- Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesisInternational Journal of Oncology, 2007
- Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotypeHuman Pathology, 2007
- Met, metastasis, motility and moreNature Reviews Molecular Cell Biology, 2003
- Scatter factor/hepatocyte growth factor is essential for liver developmentNature, 1995